As of 2025-03-24, the EV/EBITDA ratio of TherapeuticsMD Inc (TXMD) is -2.56. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TXMD's latest enterprise value is 5.21 mil USD. TXMD's TTM EBITDA according to its financial statements is -2.04 mil USD. Dividing these 2 quantities gives us the above TXMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.2x - 8.7x | 7.8x |
| Forward P/E multiples | 5.3x - 7.5x | 6.4x |
| Fair Price | (0.67) - (0.88) | (0.81) |
| Upside | -174.7% - -199.4% | -191.3% |
| Date | EV/EBITDA |